1800-272-662
Shopping Cart 0
countryflagAU
Login

Imexhs Ltd

Healthcare AU IME

0.4AUD
-(-%)

Last update at 2026-03-11T23:00:00Z

Day Range

0.400.40
LowHigh

52 Week Range

0.220.47
LowHigh

Fundamentals

  • Previous Close 0.40
  • Market Cap21.62M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.04M
  • Revenue TTM28.97M
  • Revenue Per Share TTM0.56
  • Gross Profit TTM 12.97M
  • Diluted EPS TTM-0.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.03891M -2.56800M -4.27722M -2.94623M -4.55636M
Minority interest - - - - -
Net income -2.88231M -2.62500M -4.19200M -3.03865M -4.69977M
Selling general administrative - 7.46M 5.54M 5.61M 6.09M
Selling and marketing expenses - 0.04M 0.11M 0.15M 0.14M
Gross profit 8.31M 11.03M 3.50M 17.12M 13.37M
Reconciled depreciation - 2.15M 2.43M 1.76M 1.24M
Ebit -0.69764M -2.10542M -3.68800M -2.50187M -4.23299M
Ebitda 1.52M 0.05M -1.25800M -0.74254M -2.98842M
Depreciation and amortization 2.22M 2.15M 2.43M 1.76M 1.24M
Non operating income net other - - - - -
Operating income -0.69764M -0.36711M -2.69853M -2.50187M -4.23299M
Other operating expenses 29.67M 26.90M 22.26M 19.66M 17.46M
Interest expense 0.38M 0.47M 0.33M 0.44M 0.31M
Tax provision - 0.06M 0.17M 0.09M 0.14M
Interest income - 0.03M 0.03M 0.05M 0.65M
Net interest income - -0.43693M -0.29863M -0.39603M -0.29224M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.15660M 0.06M 0.17M 0.09M 0.14M
Total revenue 28.97M 26.57M 19.67M 17.12M 13.37M
Total operating expenses 9.01M 11.36M 8.55M 19.66M 17.46M
Cost of revenue 20.66M 15.54M 16.17M 11.66M 9.29M
Total other income expense net -2.34128M -2.20072M -1.57869M -0.44437M -0.32337M
Discontinued operations - - - - -
Net income from continuing ops - -2.62545M -4.19234M -3.03865M -4.69977M
Net income applicable to common shares - -2.62545M -4.44990M -3.03865M -4.69977M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 23.73M 21.81M 22.65M 20.99M 25.76M
Intangible assets 3.30M 3.52M - 3.26M 3.01M
Earning assets - - - - -
Other current assets 0.65M 0.97M 0.27M 0.85M 0.26M
Total liab 7.86M 7.33M 6.67M 5.09M 9.11M
Total stockholder equity 15.87M 14.47M 15.98M 15.90M 16.65M
Deferred long term liab - - - - -
Other current liab 2.46M 2.94M 2.78M 1.88M 0.33M
Common stock 42.89M 40.29M 38.66M 38.48M 34.77M
Capital stock - - - 38.48M 34.77M
Retained earnings -33.21014M -30.32783M -27.44482M -23.25248M -20.21383M
Other liab - - - 0.06M 0.72M
Good will 3.35M 4.61M 4.80M 4.86M 5.32M
Other assets - - - 0.63M 1.40M
Cash 3.30M 2.07M 2.36M 1.91M 4.19M
Cash and equivalents - - - - 4.19M
Total current liabilities 7.76M 6.89M 6.37M 4.48M 7.10M
Current deferred revenue 1.20M - 0.06M - 2.47M
Net debt -2.73246M -0.88273M -1.06862M -0.79480M -1.78883M
Short term debt 0.55M 0.82M 1.08M 0.57M 1.11M
Short long term debt - - - 0.55M 1.08M
Short long term debt total 0.57M 1.19M 1.29M 1.12M 2.40M
Other stockholder equity - - 0.00000M -3.28677M 2.10M
Property plant equipment - - - 3.73M 4.50M
Total current assets 13.44M 9.26M 8.92M 8.51M 11.54M
Long term investments - - - - -
Net tangible assets - - - 7.78M 8.32M
Short term investments - - - - -
Net receivables 9.34M 5.89M 6.18M 5.37M 7.01M
Long term debt - - - 0.54M 1.29M
Inventory 0.15M 0.33M 0.11M 0.10M 0.08M
Accounts payable 3.55M 3.12M 2.45M 2.03M 3.19M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 6.19M 4.51M 4.77M 0.68M 2.10M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 1.13M 3.78M 0.63M 1.40M
Deferred long term asset charges - - - - -
Non current assets total 10.29M 12.55M 13.74M 12.48M 14.22M
Capital lease obligations - - - 0.03M 0.03M
Long term debt total - - - 0.54M 1.29M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.76591M -2.13310M -2.22244M -3.38624M
Change to liabilities - - - -1.20692M -2.28538M
Total cashflows from investing activities -1.19306M -0.76591M -2.13310M -2.22244M -3.38624M
Net borrowings - -0.10618M -0.04044M -1.36059M -1.10494M
Total cash from financing activities 1.68M 1.18M -0.09861M 2.25M -0.16178M
Change to operating activities - - - -0.31855M 0.30M
Net income -2.88231M -2.62545M -4.19234M -3.03865M -4.69977M
Change in cash 1.23M -0.28978M 0.45M -2.27452M -6.61006M
Begin period cash flow 2.07M 2.36M 1.91M 4.19M 10.80M
End period cash flow 3.30M 2.07M 2.36M 1.91M 4.19M
Total cash from operating activities 0.56M -0.63468M 2.61M -1.27932M -2.96804M
Issuance of capital stock - 1.50M - 3.98M 0.97M
Depreciation 2.22M 2.15M 2.43M 1.76M 1.24M
Other cashflows from investing activities - 0.32M -0.90222M -0.19099M -0.82153M
Dividends paid - - - - -0.50681M
Change to inventory 0.18M -0.22098M -0.01108M -0.01871M 0.29M
Change to account receivables -2.74253M -1.53916M 0.04M 0.60M 1.33M
Sale purchase of stock - -0.12276M -0.01279M -0.36279M -0.02558M
Other cashflows from financing activities -0.09034M 1.38M -0.04538M -0.08110M 0.93M
Change to netincome - - - 0.03M 0.85M
Capital expenditures 0.32M 1.06M 2.20M 2.03M 2.56M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.39152M -1.82408M 1.81M -1.62469M -0.69501M
Stock based compensation - 0.36M 0.59M - -
Other non cash items 2.62M 1.30M 3.15M 1.28M 3.46M
Free cash flow 0.24M -1.69398M 0.41M -3.31078M -5.53274M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IME
Imexhs Ltd		 - -% 0.40 - - 0.75 1.36 0.65 -30.3866
PME
Pro Medicus Ltd		 -0.55 0.41% 133.00 59.62 73.53 58.00 36.74 58.50 75.61
AYA
ARTRYA Ltd		 -0.17 5.04% 3.20 - - 17488.26 5.98 5516.69 0.33
EIQ
Echoiq Ltd		 0.02 2.94% 0.70 - - 5046.68 25.81 4779.15 -8.2701
CGS
Cogstate Ltd		 -0.02 0.92% 2.15 23.89 19.96 6.58 5.14 4.32 13.45

Reports Covered

Stock Research & News

View All

Profile

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists' interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.

Imexhs Ltd

32 Martin Place, Sydney, NSW, Australia, 2020

Key Executives

Name Title Year Born
Dr. German Arango Co-Founder, CEO & Director NA
Ms. Reena Minhas CFO & Company Sec. NA
Dr. Jorge Marin Co-Founder & Chief Medical Officer NA
Mr. Andres Vanegas Co-Founder & Strategic Accounts Mang. NA
Mr. Alexander Sanz Co-Founder & CTO NA
Mr. Alejandro Varettoni Chief Sales Officer NA
Dr. German Arango Co-Founder, CEO, MD & Director NA
Ms. Reena Minhas CFO & Company Secretary NA
Dr. German Arango Co-Founder, CEO, MD & Director NA
Ms. Reena Minhas CFO & Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.